Caribou Biosciences, Inc.
CRBU
$0.735
$0.00190.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -149.11M | -148.12M | -123.44M | -115.26M | -102.07M |
| Total Depreciation and Amortization | 3.93M | 3.48M | 3.89M | 3.65M | 3.53M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.09M | 16.32M | 14.35M | 14.86M | 12.57M |
| Change in Net Operating Assets | -5.11M | 4.21M | -15.03M | -5.81M | -7.32M |
| Cash from Operations | -138.20M | -124.11M | -120.24M | -102.56M | -93.29M |
| Capital Expenditure | -4.88M | -6.64M | -10.72M | -11.03M | -11.61M |
| Sale of Property, Plant, and Equipment | 13.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.47M | 45.84M | -45.08M | -54.90M | -56.57M |
| Cash from Investing | 86.61M | 39.20M | -55.79M | -65.93M | -68.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16.72M | 12.86M | 147.75M | 165.18M | 154.34M |
| Repurchase of Common Stock | -- | -43.00K | -43.00K | -43.00K | -43.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.72M | 12.82M | 147.70M | 165.14M | 154.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.87M | -72.09M | -28.33M | -3.34M | -7.18M |